Healthy Life Agritec Ltd
HEALTHYLIFE.BO
INR16.64 4.98%
Exchange: BSE | Sector: Consumer Defensive | Industry: Food Distribution
Q4 2023
Published: Mar 31, 2024

Earnings Highlights

  • Revenue of $463.15M up 129.8% year-over-year
  • EPS of $0.16 increased by 68.4% from previous year
  • Gross margin of 4.8%
  • Net income of 10.40M
  • "N/A" - N/A

Healthy Life Agritec Ltd (HEALTHYLIFE.BO) QQ4 2023 Earnings Review: Modest Margin Bandwidth with Robust YoY Revenue Growth in Indian Food Distribution

Executive Summary

Healthy Life Agritec Ltd delivered a solid quarterly performance for QQ4 2023, posting revenue of INR 463.15 million with a gross margin of 4.83% and a net margin of 2.25%. Despite a thin gross margin, the company produced positive EBIT and net income, supported by disciplined operating expenses and favorable working-capital dynamics. The year‑over‑year improvements across key profitability metrics—revenue up ~129.8%, gross profit up ~201.5%, operating income up ~332.6%, and net income up ~389.4%—reflect a meaningful expansion in operating leverage from a historically low base, alongside ongoing cost discipline. The balance sheet exhibits strong liquidity with a current ratio of 6.20 and a quick ratio of 5.34, underscoring the company’s ability to meet short‑term obligations even as inventories and receivables form a meaningful portion of current assets. Leverage remains modest (debt ratio ~7.5%, debt-to-equity ~9.35%), suggesting limited financial risk and ample capacity to fund modest growth or working-capital needs. On a valuation basis, the stock trades at a subdued multiple (P/E ~6.5; P/S ~0.59; P/B ~1.01), indicative of a defensively positioned, small-cap consumer staples play that could offer downside protection in volatile markets, albeit with limited near‑term visibility on explicit guidance. Critical items for investors to monitor include management’s ability to sustain margin expansion, the evolution of working-capital efficiency (DSO ~48 days, CCC ~51.7 days), and any formal guidance on revenue trajectory, capex plans, or strategic initiatives (e.g., expansion into new geographies or product lines). Given the lack of an earnings-call transcript in the provided data, investors should await explicit commentary on growth drivers, procurement strategies, and cost-shaves that could meaningfully alter profitability in the coming quarters.

Key Performance Indicators

Revenue

463.15M
QoQ: 0.00% | YoY:129.75%

Gross Profit

22.38M
4.83% margin
QoQ: 0.00% | YoY:201.46%

Operating Income

14.06M
QoQ: 0.00% | YoY:332.61%

Net Income

10.40M
QoQ: 0.00% | YoY:389.39%

EPS

0.16
QoQ: 0.00% | YoY:68.42%

Revenue Trend

Margin Analysis

Key Insights

  • Revenue: INR 463.15 million; YoY growth 129.75%; QoQ growth 0.00%
  • Gross Profit: INR 22.38 million; Gross margin 4.83%; YoY gross profit growth 201.46%; QoQ 0.00%
  • EBITDA: INR 14.45 million; EBITDA margin 3.12%
  • Operating Income: INR 14.06 million; Operating margin 3.03%
  • Net Income: INR 10.40 million; Net margin 2.25%; YoY net income growth 389.39%; QoQ 0.00%

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2026 855.27 0.66 +84.7% View
Q1 2026 427.63 0.33 +112.1% View
Q1 2024 463.15 0.16 +129.8% View
Q4 2023 463.15 0.16 +129.8% View
Q3 2023 463.15 0.46 +0.0% View